Coherus Oncology (CHRS) Revenue & Revenue Breakdown
Coherus Oncology Revenue Highlights
Latest Revenue (Y)
$42.17M
Latest Revenue (Q)
$12.31M
Main Segment (Y)
Product and Service, Other
Main Geography (Y)
UNITED STATES
Coherus Oncology Revenue by Period
Coherus Oncology Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $42.17M | -84.20% |
| 2024-12-31 | $266.96M | 3.78% |
| 2023-12-31 | $257.24M | 21.89% |
| 2022-12-31 | $211.04M | -35.37% |
| 2021-12-31 | $326.55M | -31.37% |
| 2020-12-31 | $475.82M | 33.63% |
| 2019-12-31 | $356.07M | 22783.74% |
| 2018-12-31 | $1.56M | - |
| 2017-12-31 | $1.56M | -99.18% |
| 2016-12-31 | $190.11M | 532.82% |
| 2015-12-31 | $30.04M | -3.42% |
| 2014-12-31 | $31.11M | 1030.72% |
| 2013-12-31 | $2.75M | 44.87% |
| 2012-12-31 | $1.90M | - |
Coherus Oncology generated $42.17M in revenue during NA 2025, up -84.20% compared to the previous quarter, and up 8.86% compared to the same period a year ago.
Coherus Oncology Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $12.31M | -3.44% |
| 2025-12-31 | $12.75M | 10.17% |
| 2025-09-30 | $11.57M | 12.84% |
| 2025-06-30 | $10.25M | 34.94% |
| 2025-03-31 | $7.60M | -85.97% |
| 2024-12-31 | $54.14M | -23.50% |
| 2024-09-30 | $70.77M | 8.92% |
| 2024-06-30 | $64.98M | 2715.38% |
| 2024-03-31 | $2.31M | -97.48% |
| 2023-12-31 | $91.52M | 22.74% |
| 2023-09-30 | $74.57M | 27.00% |
| 2023-06-30 | $58.72M | 81.02% |
| 2023-03-31 | $32.44M | -28.48% |
| 2022-12-31 | $45.35M | -0.16% |
| 2022-09-30 | $45.42M | -24.48% |
| 2022-06-30 | $60.15M | 0.06% |
| 2022-03-31 | $60.12M | -18.07% |
| 2021-12-31 | $73.37M | -11.07% |
| 2021-09-30 | $82.50M | -5.86% |
| 2021-06-30 | $87.64M | 5.55% |
| 2021-03-31 | $83.03M | -24.80% |
| 2020-12-31 | $110.42M | -2.76% |
| 2020-09-30 | $113.55M | -16.31% |
| 2020-06-30 | $135.67M | 16.78% |
| 2020-03-31 | $116.18M | -6.20% |
| 2019-12-31 | $123.86M | 10.90% |
| 2019-09-30 | $111.68M | 33.86% |
| 2019-06-30 | $83.43M | 124.90% |
| 2019-03-31 | $37.10M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | -100.00% |
| 2017-06-30 | $1.40M | 766.46% |
| 2017-03-31 | $161.00K | -80.92% |
| 2016-12-31 | $844.00K | -99.48% |
| 2016-09-30 | $162.84M | 1057.49% |
| 2016-06-30 | $14.07M | 13.83% |
| 2016-03-31 | $12.36M | 21.19% |
| 2015-12-31 | $10.20M | 42.29% |
| 2015-09-30 | $7.17M | 4.38% |
| 2015-06-30 | $6.87M | 18.18% |
| 2015-03-31 | $5.81M | -10.52% |
| 2014-12-31 | $6.49M | -59.55% |
| 2014-09-30 | $16.05M | 223.30% |
| 2014-06-30 | $4.96M | 38.07% |
| 2014-03-31 | $3.60M | 191.88% |
| 2013-12-31 | $1.23M | 143.48% |
| 2013-09-30 | $506.00K | - |
Coherus Oncology generated $12.31M in revenue during Q1 2026, up -3.44% compared to the previous quarter, and up 22.74% compared to the same period a year ago.
Coherus Oncology Revenue Breakdown
Coherus Oncology Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Product and Service, Other | $1.34M | $7.26M | - | - | - |
| Product | - | $259.70M | - | - | - |
| Product Revenue | - | - | $256.58M | $210.76M | $326.60M |
| Other | - | - | $664.00K | $282.00K | - |
Coherus Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product and Service, Other (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product and Service, Other | $507.00K | $388.00K | $402.00K | $295.00K | $251.00K | $7.04M | $220.00K | - | - | - | - | - | - | - | - | - |
| Product | - | - | - | - | - | $189.15M | $70.55M | $82.50M | $87.60M | $83.00M | - | - | - | - | - | - |
| Product Revenue | - | - | - | - | - | - | - | $76.74M | $165.77M | $58.46M | $32.35M | $60.10M | $73.40M | - | - | - |
| Other | - | - | - | - | - | - | - | $320.00K | $322.00K | $259.00K | $83.00K | - | - | - | - | - |
Coherus Oncology's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Product and Service, Other (100.00%).
Coherus Oncology Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 |
|---|---|
| Non Us | - |
| UNITED STATES | $356.07M |
Coherus Oncology's latest annual revenue breakdown by geography, as of Dec 19: UNITED STATES (100.00%).
Coherus Oncology Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CDXS | Codexis | $70.39M | $15.25M |
| SGMO | Sangamo Therapeutics | $57.80M | $581.00K |
| IVVD | Invivyd | $53.43M | $13.13M |
| CHRS | Coherus Oncology | $42.17M | $12.31M |
| OABI | OmniAb | $18.67M | $14.43M |
| IMDX | Insight Molecular Diagnostics | $4.05M | $260.00K |
| AVTX | Avalo Therapeutics | $59.00K | - |
| CCCC | C4 Therapeutics | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| TARA | Protara Therapeutics | - | - |